Your browser doesn't support javascript.
loading
Performance of Generative Pretrained Transformer on the National Medical Licensing Examination in Japan.
Tanaka, Yudai; Nakata, Takuto; Aiga, Ko; Etani, Takahide; Muramatsu, Ryota; Katagiri, Shun; Kawai, Hiroyuki; Higashino, Fumiya; Enomoto, Masahiro; Noda, Masao; Kometani, Mitsuhiro; Takamura, Masayuki; Yoneda, Takashi; Kakizaki, Hiroaki; Nomura, Akihiro.
Afiliação
  • Tanaka Y; School of Medicine, Kanazawa University, Kanazawa, Japan.
  • Nakata T; Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
  • Aiga K; Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Etani T; School of Medicine, Kanazawa University, Kanazawa, Japan.
  • Muramatsu R; Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
  • Katagiri S; Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Kawai H; Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
  • Higashino F; School of Medicine, Kanazawa University, Kanazawa, Japan.
  • Enomoto M; Graduate School of Media and Governance, Keio University, Fujisawa, Japan.
  • Noda M; Advanced Research Center for Human Sciences, Waseda University, Saitama, Japan.
  • Kometani M; School of Medicine, Kanazawa University, Kanazawa, Japan.
  • Takamura M; Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Yoneda T; School of Medicine, Kanazawa University, Kanazawa, Japan.
  • Kakizaki H; School of Medicine, Kanazawa University, Kanazawa, Japan.
  • Nomura A; School of Medicine, Kanazawa University, Kanazawa, Japan.
PLOS Digit Health ; 3(1): e0000433, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38261580
ABSTRACT
The remarkable performance of ChatGPT, launched in November 2022, has significantly impacted the field of natural language processing, inspiring the application of large language models as supportive tools in clinical practice and research worldwide. Although GPT-3.5 recently scored high on the United States Medical Licensing Examination, its performance on medical licensing examinations of other nations, especially non-English speaking nations, has not been sufficiently evaluated. This study assessed GPT's performance on the National Medical Licensing Examination (NMLE) in Japan and compared it with the actual minimal passing rate for this exam. In particular, the performances of both the GPT-3.5 and GPT-4 models were considered for the comparative analysis. We initially used the GPT models and several prompts for 290 questions without image data from the 116th NMLE (held in February 2022 in Japan) to maximize the performance for delivering correct answers and explanations of the questions. Thereafter, we tested the performance of the best GPT model (GPT-4) with optimized prompts on a dataset of 262 questions without images from the latest 117th NMLE (held in February 2023). The best model with the optimized prompts scored 82.7% for the essential questions and 77.2% for the basic and clinical questions, both of which sufficed the minimum passing scoring rates of 80.0% and 74.6%, respectively. After an exploratory analysis of 56 incorrect answers from the model, we identified the three major factors contributing to the generation of the incorrect answers-insufficient medical knowledge, information on Japan-specific medical system and guidelines, and mathematical errors. In conclusion, GPT-4 with our optimized prompts achieved a minimum passing scoring rate in the latest 117th NMLE in Japan. Beyond its original design of answering examination questions for humans, these artificial intelligence (AI) models can serve as one of the best "sidekicks" for solving problems and addressing the unmet needs in the medical and healthcare fields.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: PLOS Digit Health Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: PLOS Digit Health Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão